SHARES PURCHASE AGREEMENTShares Purchase Agreement • March 25th, 2024 • Fresh2 Group LTD • Services-medical laboratories • New York
SHARES PURCHASE AGREEMENT (this “Agreement”), dated as of February 20, 2024, by and between Fresh2 Group Limited, a British Virgin Islands corporation (the “Company”), and Hong Qin (the “Investor”).
SUPPLEMENTAL AGREEMENTSupplemental Agreement • March 25th, 2024 • Fresh2 Group LTD • Services-medical laboratories • New York
This supplemental agreement (the “Supplemental Agreement”) is made and entered into as of [*] (the “Effective Date”), between Fresh2 Group Limited (the “Company”), and ***INC (the “Investor”) (Each, “Party”, or collectively, “Parties”).
SUPPLEMENTAL AGREEMENTSupplemental Agreement • March 25th, 2024 • Fresh2 Group LTD • Services-medical laboratories • New York
This supplemental agreement (the “Supplemental Agreement”) is made and entered into as of February 20, 2024 (the “Effective Date”), between Fresh2 Group Limited (formerly, “AnPac Bio-Medical Science Co., Ltd.”) (the “Company”), and Applegreen LLC (the “Investor”) (Each, “Party”, or collectively, “Parties”).
AMENDMENT TO SHARE PURCHASE AGREEMENTShare Purchase Agreement • March 25th, 2024 • Fresh2 Group LTD • Services-medical laboratories
Amendment to the Share Purchase Agreement, dated as of [*], 2024 (this “Amendment”), is entered into by and among Fresh2 Group Limited (the “Company”), and [*] (the “Investor”) (each a “Party” and together with the Company, the “Parties”).
AMENDMENT TO SHARE PURCHASE AGREEMENTShare Purchase Agreement • March 25th, 2024 • Fresh2 Group LTD • Services-medical laboratories
Amendment to the Share Purchase Agreement, dated as of February 20, 2024 (this “Amendment”), is entered into by and among Fresh2 Group Limited (the “Company”), and Applegreen LLC (the “Investor”) (each a “Party” and together with the Company, the “Parties”).
